BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Business

  ThermoGenesis to Announce Fourth Quarter and Year End Results on September 9

  September 9, 2009

   · 

  3 min read
• Genetown

  Verenium Corporation Announces Reverse Stock Split to Take Effect September 9

  September 9, 2009

   · 

  1 min read
• Business

  Laureate Pharma, Inc. and Neoprobe Corporation Announce Manufacturing Alliance

  September 9, 2009

   · 

  1 min read
• Drug Development

  Oramed Pharmaceuticals Inc. Commences Human Clinical Trials of an Oral GLP-1 Analog ORMD 0901 is Being Developed as an Oral Dosage Form of a GLP-1 Analog Aimed at Improving Glycemic Control in Adults with Type 2 Diabetes

  September 9, 2009

   · 

  3 min read
• Biotech Bay

  Alexza Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference

  September 9, 2009

   · 

  1 min read
• Biotech Beach

  Shrink Nanotechnologies to Present at Rodman & Renshaw Annual Global Investment Conference on Friday, September 11th

  September 9, 2009

   · 

  1 min read
• Pharm Country

  SyntheMed, Inc. Receives Brazilian Regulatory Approval for REPEL-CV(TM)

  September 9, 2009

   · 

  1 min read
• BioCapital

  Cytomedix Inc. CEO Issues Shareholder Update

  September 9, 2009

   · 

  1 min read
• Drug Development

  Chelsea Therapeutics, Inc. Achieves Target Enrollment in Second Pivotal Phase III Trial of Droxidopa in Neurogenic Orthostatic Hypotension

  September 9, 2009

   · 

  1 min read
• Biotech Bay

  Medivation, Inc. Announces Participation in Upcoming Conferences

  September 9, 2009

   · 

  1 min read